METTL16 and cancer: Given METTL16's role in DNA damage repair through RNA methylation, SAM metabolism regulation, and coordination of the cell cycle and DNA repair, a combination of METTL16 inhibitors with PARP inhibitors could effectively target cancer cells with DNA repair deficiencies, thereby enhancing therapeutic efficacy.56